Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HAEMONETICS CORP Director's Dealing 2016

Aug 19, 2016

31565_dirs_2016-08-19_f743a3d5-0d96-4de4-8207-80b960d0c501.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2016-08-17

Reporting Person: MERRIMAN RONALD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-08-17 Common Stock S 100 $35.09 Disposed 22088 Direct
2016-08-17 Common Stock S 100 $35.10 Disposed 21988 Direct
2016-08-17 Common Stock S 100 $35.105 Disposed 21888 Direct
2016-08-17 Common Stock S 100 $35.11 Disposed 21788 Direct
2016-08-17 Common Stock S 100 $35.115 Disposed 21688 Direct
2016-08-17 Common Stock S 187 $35.12 Disposed 21501 Direct
2016-08-17 Common Stock S 200 $35.125 Disposed 21301 Direct
2016-08-17 Common Stock S 2500 $35.13 Disposed 18801 Direct
2016-08-17 Common Stock S 100 $35.155 Disposed 18701 Direct
2016-08-17 Common Stock S 200 $35.165 Disposed 18501 Direct
2016-08-17 Common Stock S 110 $35.17 Disposed 18391 Direct
2016-08-17 Common Stock S 100 $35.20 Disposed 18291 Direct
2016-08-17 Common Stock S 130 $35.205 Disposed 18161 Direct
2016-08-17 Common Stock S 300 $35.21 Disposed 17861 Direct
2016-08-17 Common Stock S 10 $35.215 Disposed 17851 Direct